03:51 PM EST - Response Biomedical Corp. : reported a narrower net loss of $9.54 million or $0.04 per share compared with $13.66 million or $0.10 per share a year ago. The company recorded total revenues of $9.95 million, an increase of 69% compared with $5.88 million in 2008. Clinical products revenue for the year ended December 31, 2009 grew 85% to $6.83 million from $3.68 million in 2008. Response Biomedical Corp.
shares T.RBM are trading down $0.01 at $0.16.